ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 327 filers reported holding ROYALTY PHARMA PLC in Q1 2023. The put-call ratio across all filers is 0.47 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $35,664 | +5.1% | 1,314,079 | +19.1% | 0.02% | +4.8% |
| Q2 2023 | $33,928 | +117.3% | 1,103,665 | +154.6% | 0.02% | +200.0% |
| Q1 2023 | $15,617 | -1.8% | 433,461 | +7.8% | 0.01% | 0.0% |
| Q4 2022 | $15,896 | -99.8% | 402,190 | +82.2% | 0.01% | -30.0% |
| Q3 2022 | $8,868,000 | +0.1% | 220,693 | +4.7% | 0.01% | +100.0% |
| Q2 2022 | $8,862,000 | +22.6% | 210,779 | +13.6% | 0.01% | -16.7% |
| Q1 2022 | $7,231,000 | – | 185,560 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SIGULER GUFF ADVISERS, LLC | 6,761,970 | $294,957,000 | 88.74% |
| Vantage Consulting Group Inc | 8,705,551 | $379,735,000 | 76.23% |
| Memorial Sloan Kettering Cancer Center | 2,680,644 | $116,930,000 | 72.07% |
| HARVARD MANAGEMENT CO INC | 10,714,284 | $467,357,000 | 26.11% |
| ROBERT WOOD JOHNSON FOUNDATION | 970,151 | $4,231,798,000 | 21.59% |
| Brown University | 381,759 | $16,652,000 | 11.44% |
| Overbrook Management Corp | 771,155 | $33,638,000 | 7.48% |
| SpiderRock Advisors, LLC | 778,800 | $34,236,000 | 4.79% |
| Renaissance Capital LLC | 452,948 | $19,758,000 | 2.93% |
| Lagoda Investment Management, L.P. | 104,835 | $4,573,000 | 2.28% |